Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in Kawasaki disease

  • Jun, Heul (Department of Pediatrics, Konyang University College of Medicine) ;
  • Ko, Kyung Ok (Department of Pediatrics, Konyang University College of Medicine) ;
  • Lim, Jae Woo (Department of Pediatrics, Konyang University College of Medicine) ;
  • Yoon, Jung Min (Department of Pediatrics, Konyang University College of Medicine) ;
  • Lee, Gyung Min (Department of Pediatrics, Konyang University College of Medicine) ;
  • Cheon, Eun Jung (Department of Pediatrics, Konyang University College of Medicine)
  • Received : 2015.10.30
  • Accepted : 2016.06.01
  • Published : 2016.07.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Recent reports showed that plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) could be a useful biomarker of intravenous immunoglobulin (IVIG) unresponsiveness and coronary artery lesion (CAL) development in Kawasaki disease (KD). The levels of these peptides are critically influenced by age; hence, the normal range and upper limits for infants and children are different. We performed an age-adjusted analysis of plasma NT-proBNP level to validate its clinical use in the diagnosis of KD. Methods: The data of 131 patients with KD were retrospectively analyzed. The patients were divided into 2 groups-group I (high NT-proBNP group) and group II (normal NT-proBNP group)-comprising patients with NT-proBNP concentrations higher and lower than the 95th percentile of the reference value, respectively. We compared the laboratory data, responsiveness to IVIG, and the risk of CAL in both groups. Results: Group I showed significantly higher white blood cell count, absolute neutrophil count, C-reactive protein level, aspartate aminotransferase level, and troponin-I level than group II (P<0.05). The risk of CAL was also significantly higher in group I (odds ratio, 5.78; P=0.012). IVIG unresponsiveness in group I was three times that in group II (odds ratio, 3.35; P= 0.005). Conclusion: Age-adjusted analysis of plasma NT-proBNP level could be helpful in predicting IVIG unresponsiveness and risk of CAL development in patients with KD.

Keywords

References

  1. Lee CA. Kawasaki disease. J Insur Med 2003;35:125-7.
  2. Lee DW, Kim YH, Hyun MC, Kwon TC, Lee SB. NT-proBNP as a useful tool in diagnosing incomplete Kawasaki disease. Korean J Pediatr 2010;53:519-24. https://doi.org/10.3345/kjp.2010.53.4.519
  3. Lee H, Kim H, Kim HS, Sohn S. NT-pro BNP: a new diagnostic screening tool for Kawasaki disease. Korean J Pediatr 2006;49:539-44. https://doi.org/10.3345/kjp.2006.49.5.539
  4. Bang S, Yu JJ, Han MK, Ko HK, Chun S, Choi HS, et al. Logtransformed plasma level of brain natriuretic peptide during the acute phase of Kawasaki disease is quantitatively associated with myocardial dysfunction. Korean J Pediatr 2011;54:340-4. https://doi.org/10.3345/kjp.2011.54.8.340
  5. Kaneko K, Yoshimura K, Ohashi A, Kimata T, Shimo T, Tsuji S. Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide. Pediatr Cardiol 2011;32:1106-9. https://doi.org/10.1007/s00246-011-9986-8
  6. Nir A, Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology. J Card Fail 2005;11(5 Suppl):S76-80. https://doi.org/10.1016/j.cardfail.2005.04.009
  7. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33. https://doi.org/10.1542/peds.2004-2182
  8. McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, et al. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 2007;116:174-9. https://doi.org/10.1161/CIRCULATIONAHA.107.690875
  9. Mir TS, Laux R, Hellwege HH, Liedke B, Heinze C, von Buelow H, et al. Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics 2003;112:896-9. https://doi.org/10.1542/peds.112.4.896
  10. Rauh M, Koch A. Plasma N-terminal pro-B-type natriuretic peptide concentrations in a control population of infants and children. Clin Chem 2003;49:1563-4. https://doi.org/10.1373/49.9.1563
  11. Hammerer-Lercher A, Mair J, Tews G, Puschendorf B, Sommer R. N-terminal pro-B-type natriuretic peptide concentrations are markedly higher in the umbilical cord blood of newborns than in their mothers. Clin Chem 2005;51:913-5. https://doi.org/10.1373/clinchem.2004.046557
  12. Kim HK, Oh J, Hong YM, Sohn S. Parameters to guide retreatment after initial intravenous immunoglobulin therapy in kawasaki disease. Korean Circ J 2011;41:379-84. https://doi.org/10.4070/kcj.2011.41.7.379

Cited by

  1. Diagnosing Incomplete Kawasaki Disease vol.6, pp.3, 2016, https://doi.org/10.4103/sjmms.sjmms_166_17
  2. Dengue-Triggered Kawasaki Disease : A Report of 2 Cases vol.24, pp.7, 2018, https://doi.org/10.1097/rhu.0000000000000704
  3. N-terminal probrain natriuretic peptide as biomarker for diagnosis of Kawasaki disease vol.13, pp.4, 2016, https://doi.org/10.2217/bmm-2018-0324
  4. Cardiovascular Involvement in Kawasaki Disease Is Much More Than Mere Coronary Arteritis vol.8, pp.None, 2016, https://doi.org/10.3389/fped.2020.526969
  5. N-terminal pro-B-type natriuretic peptide levels in children: comparison in cardiac and non-cardiac diseases vol.30, pp.4, 2020, https://doi.org/10.1017/s1047951120000402
  6. Predictive value of heart rate deceleration capacity on coronary artery lesion in acute phase of Kawasaki disease vol.10, pp.None, 2020, https://doi.org/10.1038/s41598-020-67121-3